Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Inflammatory Bowel Diseases | 18 | 2021 | 3209 | 2.33 | Why? |
| Colitis, Ulcerative | 4 | 2019 | 1037 | 1.16 | Why? |
| Ear Diseases | 2 | 2018 | 58 | 0.84 | Why? |
| Insurance, Health, Reimbursement | 1 | 2021 | 205 | 0.78 | Why? |
| Herpes Zoster | 3 | 2019 | 331 | 0.75 | Why? |
| Polychondritis, Relapsing | 1 | 2018 | 20 | 0.73 | Why? |
| Tablets, Enteric-Coated | 1 | 2017 | 6 | 0.71 | Why? |
| Central Serous Chorioretinopathy | 1 | 2017 | 20 | 0.69 | Why? |
| Pouchitis | 1 | 2017 | 20 | 0.69 | Why? |
| Hepatitis B Antibodies | 1 | 2018 | 142 | 0.66 | Why? |
| Crohn Disease | 4 | 2018 | 959 | 0.63 | Why? |
| Behcet Syndrome | 1 | 2018 | 136 | 0.62 | Why? |
| Vaccines | 3 | 2021 | 3692 | 0.60 | Why? |
| Hepatitis B Vaccines | 1 | 2018 | 245 | 0.60 | Why? |
| Budesonide | 1 | 2017 | 192 | 0.57 | Why? |
| Vaccination | 8 | 2021 | 19050 | 0.54 | Why? |
| Colorectal Neoplasms | 3 | 2018 | 1884 | 0.54 | Why? |
| Pharmacies | 1 | 2019 | 356 | 0.53 | Why? |
| Infliximab | 1 | 2018 | 502 | 0.51 | Why? |
| Preventive Medicine | 1 | 2017 | 242 | 0.51 | Why? |
| Disclosure | 1 | 2017 | 423 | 0.50 | Why? |
| Opportunistic Infections | 1 | 2019 | 602 | 0.47 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2019 | 830 | 0.47 | Why? |
| Anaphylaxis | 1 | 2021 | 940 | 0.45 | Why? |
| Endoscopy | 2 | 2020 | 1564 | 0.44 | Why? |
| Osteoporosis | 1 | 2017 | 410 | 0.44 | Why? |
| Hypersensitivity | 1 | 2021 | 1137 | 0.43 | Why? |
| Social Stigma | 1 | 2017 | 1049 | 0.37 | Why? |
| Uterine Cervical Neoplasms | 1 | 2017 | 842 | 0.36 | Why? |
| Gastroenterologists | 2 | 2021 | 259 | 0.33 | Why? |
| Practice Guidelines as Topic | 2 | 2021 | 15421 | 0.32 | Why? |
| Immunocompromised Host | 3 | 2022 | 5150 | 0.32 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.30 | Why? |
| Practice Patterns, Physicians' | 2 | 2021 | 4927 | 0.30 | Why? |
| Immunosuppressive Agents | 3 | 2019 | 6331 | 0.30 | Why? |
| Gastrointestinal Diseases | 1 | 2019 | 2580 | 0.27 | Why? |
| Chickenpox | 2 | 2017 | 194 | 0.26 | Why? |
| Skin Neoplasms | 1 | 2017 | 1679 | 0.25 | Why? |
| Clinical Audit | 1 | 2020 | 204 | 0.20 | Why? |
| Tumor Necrosis Factor-alpha | 3 | 2019 | 2483 | 0.19 | Why? |
| Students | 1 | 2017 | 5255 | 0.19 | Why? |
| Narrow Band Imaging | 1 | 2018 | 24 | 0.18 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 8811 | 0.18 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.18 | Why? |
| Proctocolectomy, Restorative | 1 | 2018 | 51 | 0.18 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.17 | Why? |
| Esophageal Diseases | 1 | 2017 | 34 | 0.17 | Why? |
| Coloring Agents | 1 | 2018 | 116 | 0.17 | Why? |
| Vulvar Diseases | 1 | 2016 | 38 | 0.16 | Why? |
| Microscopy, Confocal | 1 | 2018 | 343 | 0.16 | Why? |
| Colitis | 1 | 2019 | 266 | 0.16 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 694 | 0.16 | Why? |
| Herpesvirus 3, Human | 1 | 2017 | 228 | 0.15 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.14 | Why? |
| Ustekinumab | 1 | 2016 | 216 | 0.14 | Why? |
| Mouth Diseases | 1 | 2017 | 193 | 0.14 | Why? |
| Hepatitis, Viral, Human | 1 | 2017 | 196 | 0.13 | Why? |
| Adalimumab | 1 | 2018 | 389 | 0.13 | Why? |
| Meningococcal Infections | 1 | 2017 | 216 | 0.13 | Why? |
| Wound Healing | 1 | 2017 | 424 | 0.13 | Why? |
| Erythema | 1 | 2018 | 400 | 0.13 | Why? |
| Endoscopy, Gastrointestinal | 2 | 2018 | 1545 | 0.12 | Why? |
| Hidradenitis Suppurativa | 1 | 2017 | 309 | 0.12 | Why? |
| Health Care Costs | 1 | 2020 | 1007 | 0.11 | Why? |
| Colonoscopy | 1 | 2018 | 738 | 0.11 | Why? |
| Humans | 31 | 2022 | 930598 | 0.11 | Why? |
| Endoscopes, Gastrointestinal | 1 | 2010 | 11 | 0.11 | Why? |
| Immunologic Factors | 2 | 2018 | 4206 | 0.11 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.11 | Why? |
| Dermatologic Agents | 1 | 2016 | 489 | 0.10 | Why? |
| Hepatitis B virus | 1 | 2018 | 882 | 0.10 | Why? |
| Pneumococcal Infections | 1 | 2017 | 562 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.10 | Why? |
| Device Approval | 1 | 2010 | 93 | 0.10 | Why? |
| Pharmacists | 1 | 2020 | 1246 | 0.10 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.09 | Why? |
| Equipment Failure | 1 | 2010 | 197 | 0.09 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.09 | Why? |
| Papillomavirus Infections | 1 | 2017 | 861 | 0.09 | Why? |
| Diarrhea | 1 | 2019 | 2743 | 0.08 | Why? |
| Varicose Veins | 1 | 2006 | 30 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.08 | Why? |
| Medical Records Systems, Computerized | 1 | 2008 | 159 | 0.08 | Why? |
| Eye Diseases | 1 | 2017 | 1150 | 0.08 | Why? |
| Mesenteric Veins | 1 | 2006 | 60 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.08 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.07 | Why? |
| Health Literacy | 1 | 2016 | 1078 | 0.07 | Why? |
| Clinical Competence | 1 | 2021 | 3263 | 0.07 | Why? |
| Surveys and Questionnaires | 4 | 2021 | 43792 | 0.07 | Why? |
| Early Detection of Cancer | 1 | 2017 | 1956 | 0.07 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2010 | 663 | 0.07 | Why? |
| Antibody Formation | 1 | 2018 | 4038 | 0.07 | Why? |
| Endoscopy, Digestive System | 1 | 2008 | 352 | 0.07 | Why? |
| Intestine, Small | 1 | 2006 | 336 | 0.06 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| United States Food and Drug Administration | 1 | 2010 | 1276 | 0.06 | Why? |
| Universities | 1 | 2017 | 4374 | 0.06 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.06 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.06 | Why? |
| Decision Making | 1 | 2016 | 3132 | 0.06 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.05 | Why? |
| Female | 10 | 2020 | 380317 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Adult | 8 | 2020 | 244371 | 0.05 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2006 | 669 | 0.05 | Why? |
| Travel | 1 | 2019 | 7220 | 0.05 | Why? |
| Skin Diseases | 1 | 2016 | 2509 | 0.05 | Why? |
| Male | 8 | 2020 | 367725 | 0.05 | Why? |
| Anastomotic Leak | 1 | 2018 | 46 | 0.05 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.05 | Why? |
| Abdominal Abscess | 1 | 2018 | 41 | 0.05 | Why? |
| Intestinal Fistula | 1 | 2018 | 43 | 0.05 | Why? |
| Decision Trees | 1 | 2020 | 441 | 0.04 | Why? |
| Endoscopic Mucosal Resection | 1 | 2018 | 63 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.04 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2022 | 782 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Intestinal Obstruction | 1 | 2018 | 197 | 0.04 | Why? |
| Social Media | 1 | 2017 | 5798 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Preventive Health Services | 1 | 2021 | 501 | 0.04 | Why? |
| United States | 3 | 2020 | 46150 | 0.04 | Why? |
| Retrospective Studies | 4 | 2022 | 105322 | 0.04 | Why? |
| Patient Participation | 1 | 2021 | 829 | 0.03 | Why? |
| Colectomy | 1 | 2016 | 327 | 0.03 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Comprehension | 1 | 2016 | 259 | 0.03 | Why? |
| Physician's Role | 1 | 2021 | 853 | 0.03 | Why? |
| Depression | 1 | 2017 | 14116 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Medical Device Recalls | 1 | 2010 | 5 | 0.03 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.03 | Why? |
| Professional Role | 1 | 2020 | 1280 | 0.03 | Why? |
| Middle Aged | 6 | 2020 | 270681 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2016 | 15909 | 0.02 | Why? |
| Gastroenterology | 1 | 2020 | 1352 | 0.02 | Why? |
| Equipment Safety | 1 | 2010 | 167 | 0.02 | Why? |
| Communication | 2 | 2017 | 5206 | 0.02 | Why? |
| Forms and Records Control | 1 | 2008 | 32 | 0.02 | Why? |
| Attitude | 1 | 2017 | 1481 | 0.02 | Why? |
| Product Surveillance, Postmarketing | 1 | 2010 | 189 | 0.02 | Why? |
| Phlebography | 1 | 2006 | 65 | 0.02 | Why? |
| Liver Cirrhosis, Alcoholic | 1 | 2006 | 32 | 0.02 | Why? |
| Video-Assisted Surgery | 1 | 2006 | 43 | 0.02 | Why? |
| Physician-Patient Relations | 1 | 2016 | 1266 | 0.02 | Why? |
| Off-Label Use | 1 | 2010 | 553 | 0.02 | Why? |
| Compassionate Use Trials | 1 | 2010 | 632 | 0.02 | Why? |
| Patient Selection | 1 | 2020 | 4560 | 0.02 | Why? |
| Esophageal and Gastric Varices | 1 | 2006 | 117 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2017 | 51949 | 0.02 | Why? |
| Portal Vein | 1 | 2006 | 193 | 0.02 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.02 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.01 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| HIV Infections | 1 | 2022 | 11620 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Information Dissemination | 1 | 2008 | 2986 | 0.01 | Why? |
| Aged | 1 | 2020 | 215776 | 0.00 | Why? |
| Animals | 1 | 2010 | 78931 | 0.00 | Why? |
Farraye's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(173)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_